Statements (30)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:drug
|
| gptkbp:activeIngredient |
gptkb:Heparin_Sodium
|
| gptkbp:antidote |
gptkb:Protamine_sulfate
|
| gptkbp:approvedBy |
1930s
|
| gptkbp:ATCCode |
gptkb:B01AB01
|
| gptkbp:contraindication |
Active bleeding
Severe thrombocytopenia |
| gptkbp:form |
gptkb:Injection
|
| https://www.w3.org/2000/01/rdf-schema#label |
Heparin Sodium Injection
|
| gptkbp:legalStatus |
Prescription only
|
| gptkbp:manufacturer |
gptkb:Pfizer
gptkb:Fresenius_Kabi gptkb:Baxter_International |
| gptkbp:mechanismOfAction |
Anticoagulant
|
| gptkbp:monitoredParameter |
aPTT
Platelet count |
| gptkbp:pregnancyCategory |
C
|
| gptkbp:routeOfAdministration |
Intravenous
Subcutaneous |
| gptkbp:sideEffect |
gptkb:Thrombocytopenia
Bleeding Osteoporosis (with long-term use) |
| gptkbp:storage |
Room temperature
|
| gptkbp:usedFor |
Prevention of blood clots
Prevention of clotting in medical devices Treatment of deep vein thrombosis Treatment of pulmonary embolism |
| gptkbp:WHOModelListOfEssentialMedicines |
Yes
|
| gptkbp:bfsParent |
gptkb:Heparin_Sodium
|
| gptkbp:bfsLayer |
7
|